Study Stopped
Business decision to discontinue the study. Discontinuation is not related to any patient safety or performance issues.
RITUAL Ultivision AI CADe Randomized Controlled Trial
RITUAL
Randomized Clinical Trial of the Ultivision AI Artificial Intelligence System for Colorectal Cancer Screening or Surveillance in Colonoscopy
1 other identifier
interventional
137
3 countries
4
Brief Summary
Ultivision AI is a computer-assisted detection (CADe) device intended to aid endoscopists in the real-time identification of colonic mucosal lesions (such as polyps and adenomas). Ultivision AI CADe is indicated for white light colonoscopy only.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2023
Shorter than P25 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2023
CompletedFirst Posted
Study publicly available on registry
February 16, 2023
CompletedStudy Start
First participant enrolled
July 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 23, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 23, 2024
CompletedMay 13, 2024
February 1, 2023
7 months
February 7, 2023
May 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Adenoma per Colonoscopy (APC)
Superiority of Ultivision-AI arm versus control arm. APC is defined as the total number of histologically confirmed adenomas resected divided by the total number of colonoscopies.
During the procedure/surgery
Adenoma Per Extraction (APE).
Non inferiority of Ultivision-AI arm versus control arm. Where APE is the fraction of adenoma, sessile serrated lesions, and large (\>10mm) hyperplastic polyps of the proximal colon (caecum, ascending colon, hepatic flexure, and transverse colon) out of total number of resections.
During the procedure/surgery
Study Arms (2)
Ultivision AI colonoscopy (CADe Arm)
EXPERIMENTALUltivision AI is used to aid in real-time detection of adenomas.
Standard colonoscopy (Control Arm)
ACTIVE COMPARATORPatients will undergo standard colonoscopy without AI.
Interventions
Ultivision AI is a computer-assisted detection (CADe) device intended to aid endoscopists in the real-time identification of colonic mucosal lesions (such as polyps and adenomas) in adult patients undergoing colorectal cancer screening and surveillance examinations.
Eligibility Criteria
You may qualify if:
- Age 45 to 75 years;
- Screening or surveillance colonoscopy.
- Iinformed consent
You may not qualify if:
- Colorectal cancer;
- Inflammatory bowel disease, including Crohn's disease or ulcerative colitis;
- Polyposis syndrome including Familial Adenomatous Polyposis, Cowden syndome, Linch syndrome, Peutz-Jeghers syndrome, MUITYH associated polyposis, familial Colorectal Cancer type X;
- Positive Fecal Immunochemical Test;
- Use anti-platelet agents or anticoagulants that prevent polyps removal;
- Colon resection, not including the appendix;
- Subject is pregnant or lactating.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Satisfai Health, Inc.lead
- Meditrial USA Inc.collaborator
Study Sites (4)
UC Irvine
Irvine, California, 92697, United States
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
University of Montreal Research Center (CRCHUM)
Montréal (Québec), Montreal, H2X 0A9, Canada
Humanitas Research Hospital
Milan, Italy
Related Publications (1)
Urban G, Tripathi P, Alkayali T, Mittal M, Jalali F, Karnes W, Baldi P. Deep Learning Localizes and Identifies Polyps in Real Time With 96% Accuracy in Screening Colonoscopy. Gastroenterology. 2018 Oct;155(4):1069-1078.e8. doi: 10.1053/j.gastro.2018.06.037. Epub 2018 Jun 18.
PMID: 29928897RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Pathologist is blind to group assignment
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2023
First Posted
February 16, 2023
Study Start
July 21, 2023
Primary Completion
February 23, 2024
Study Completion
February 23, 2024
Last Updated
May 13, 2024
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share